ArticleTherapeutic advances in medical oncology2026
NALIRIFOX versus liposomal irinotecan plus fluorouracil/leucovorin as the second-line chemotherapy in gemcitabine refractory pancreatic adenocarcinoma: a real-world study.
Wei-Ze Wong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.